Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Eleanor Simpson will be talking about her behavioural pharmacology experiments with a functionally selective 5-HT 2C ligand (MS currently in revision) and some in vivo ( with behavior) FSCV experiments that they have done with this drug.

host: Mark Walton